A significant increase in the number of IL-10+-expressing CD19+CD20+CD5+CD1d+ Bregs was detected in the blood of patients with MASLD compared with that in the blood of healthy controls (Fig. S8C), and the same trend was observed in mice (Fig. S8D). Here, CD19 is linked to metabolic dysfunction-associated steatotic liver disease.